Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Member Company Press Release

CHAIN Biotechnology: Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that support oral delivery for OVM’s recombinant overlapping peptide (ROP) cancer vaccines.

Read the rest of entry »

Leaf Expression Systems Launch First Line of Hypertrans® Research Products

29 May 2019: Norwich, UK Leaf Expression Systems, a contract development and manufacturing organisation specialising in the plant-based expression and production of proteins, vaccines, metabolites and complex natural proteins, has announced the launch of its online list of products available for purchase by researchers working within the life sciences and agricultural industries.

Read the rest of entry »

Leaf Expression Systems Ltd: Plant Bioscience Ltd transfers control of Hypertrans® plant-based biologics and vaccines expression technology to Leaf Expression Systems Ltd

14 May 2019: Norwich Plant Bioscience Ltd (PBL) and Leaf Expression Systems Ltd (Leaf) are delighted to announce a further development in their relationship, with PBL granting Leaf the exclusive rights to sub-license the Hypertrans® transient expression system, the core technology underpinning Leaf’s biologics and vaccines contract development and manufacturing services business.

Read the rest of entry »

World Courier: White Paper: Logistics by Design - a Framework for Advanced Therapy Developers

The Logistics by Design white paper uses a risk based framework that identifies areas within your supply chain that need to be addressed at the earliest possible moment.

Read the rest of entry »

Blue Earth Diagnostics Announces Addition of Axumin® (fluciclovine (18F)) to EAU Guidelines for imaging in patients with biochemical recurrence in Prostate Cancer

Oxford, UK – April 16, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that Axumin (fluciclovine (18F)) has recently been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer (PCa).

Read the rest of entry »

CHAIN Appoints New Non-Executive Directors

MARLOW & NOTTINGHAM, UK. -- April 8, 2019 – UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.

Read the rest of entry »

N-Site Life Sciences Knowledge Portal is now free for all subscribers

N-site is a unique knowledge portal for life sciences companies containing guidance on tax, legal and IP specialisms. This resource is now free to sign up and use for all registering companies. New guidance notes have also been added along with a suite of workshops. See N-Site.co.uk for further details.

Read the rest of entry »

New appointments strengthen the Aigenpulse Leadership team

Aigenpulse Ltd., (Aigenpulse), a big data technology company which specialises in structuring, integrating and deriving meaning from large, disparate data assets in the life sciences sector, is continuing to strengthen its management team with the addition of Head of Delivery and Head of DevOps.

Read the rest of entry »

Wickham Labs Announces Upcoming Webinar on Microbiological Considerations in Cleanroom Validation

Wickham Laboratories is proud to present a live webinar on 'Microbiological Considerations in Cleanroom Validation' conducted by our Microbiology Business Support Co-ordinator and one of our QC Laboratory Senior Technicians.

Read the rest of entry »

Innovate UK Awards OBN Member Medherant a Medicines Manufacturing Grant

Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UK. The grant will enable the Company to buy equipment and move forward with its plans to extend its pilot scale manufacture of patches formulated with its unique TEPI Patch® technology to GMP manufacture for clinical trials.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.